Zhong Ji Longevity Science Group Limited (HK:0767)
:0767
Top Page
Zhong Ji Longevity Science Group Limited
(0767)
Select Model
Select Model
Rating:50Neutral
Price Target:
HK$0.49
▼(-3.92% Downside)
Action:ReiteratedDate:11/21/25
The overall stock score of 50 reflects a combination of mixed financial performance, neutral technical indicators, and challenging valuation metrics. The company's strong balance sheet is offset by cash flow issues and negative profitability, while technical analysis suggests a lack of strong momentum. The absence of earnings call data and corporate events limits additional insights.
Positive Factors
Debt-free balance sheet
A debt-free capital structure gives the company durable financial flexibility to absorb shocks, finance strategic initiatives, or invest in product and distribution without interest burdens. This structural strength supports survival during cash flow volatility and reduces refinancing risk.
Negative Factors
Weak cash generation
Persistent negative or weak operating cash conversion and absent free cash flow create a structural funding gap. Over months, this undermines the company’s ability to self-fund growth, pay suppliers, or absorb shocks, increasing reliance on external financing or equity dilution.
Read all positive and negative factors
Positive Factors
Negative Factors
Debt-free balance sheet
A debt-free capital structure gives the company durable financial flexibility to absorb shocks, finance strategic initiatives, or invest in product and distribution without interest burdens. This structural strength supports survival during cash flow volatility and reduces refinancing risk.
Read all positive factors
Zhong Ji Longevity Science Group Limited (0767) vs. iShares MSCI Hong Kong ETF (EWH)
Market Cap
HK$299.23M
Dividend YieldN/A
Average Volume (3M)487.89K
Price to Earnings (P/E)―
Beta (1Y)-0.07
Revenue Growth121.54%
EPS Growth-8360.00%
CountryHK
Employees55
SectorFinancial
Sector Strength70
IndustryFinancial - Credit Services
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding636,654,300
10 Day Avg. Volume325,210
30 Day Avg. Volume487,892
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.31
Price to Sales (P/S)0.68
P/FCF Ratio-1.85
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Zhong Ji Longevity Science Group Limited Business Overview & Revenue Model
Company Description
Zhong Ji Longevity Science Group Limited, an investment holding company, engages in the money lending business in Hong Kong and Mainland China. The company is involved in the provision of diagnostic consultation, and health and medical testing and...
How the Company Makes Money
Zhong Ji Longevity Science Group Limited generates revenue primarily through the sale of its health supplements and traditional Chinese medicine products. The company operates a multi-channel distribution model, which includes direct sales through...
Zhong Ji Longevity Science Group Limited Financial Statement Overview
Summary
Income Statement
55
Neutral
Balance Sheet
70
Positive
Cash Flow
40
Negative
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 174.06M | 168.63M | 64.99M | 89.44M | 62.98M | 81.41M |
| Gross Profit | 174.06M | 57.41M | 56.28M | 79.41M | 49.40M | 71.83M |
| EBITDA | -17.56M | -23.10M | 13.02M | 15.99M | 16.13M | -11.89M |
| Net Income | -46.43M | -34.73M | 2.31M | -904.00K | 6.05M | -11.49M |
Balance Sheet | ||||||
| Total Assets | 509.39M | 525.63M | 509.25M | 484.84M | 517.50M | 478.24M |
| Cash, Cash Equivalents and Short-Term Investments | 30.04M | 47.84M | 81.08M | 60.07M | 19.44M | 40.80M |
| Total Debt | 12.77M | 19.11M | 20.20M | 11.76M | 12.93M | 8.70M |
| Total Liabilities | 77.85M | 125.49M | 78.79M | 63.99M | 46.78M | 23.35M |
| Stockholders Equity | 404.98M | 373.42M | 403.40M | 393.83M | 443.75M | 428.83M |
Cash Flow | ||||||
| Free Cash Flow | -106.77M | -61.76M | 15.28M | 11.08M | -40.51M | -192.89M |
| Operating Cash Flow | -104.97M | -61.05M | 15.28M | 12.11M | -39.62M | -191.54M |
| Investing Cash Flow | 10.45M | 11.47M | 382.00K | 16.59M | 2.91M | 70.11M |
| Financing Cash Flow | 20.18M | 15.17M | 6.02M | -7.45M | 3.44M | -1.43M |
Zhong Ji Longevity Science Group Limited Technical Analysis
Negative
0.51
Price Trends
0.49
Negative
0.51
Negative
0.53
Negative
Market Momentum
<0.01
Positive
44.97
Neutral
70.37
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:0767, the sentiment is Negative. The current price of 0.51 is above the 20-day moving average (MA) of 0.49, above the 50-day MA of 0.49, and below the 200-day MA of 0.53, indicating a bearish trend. The MACD of <0.01 indicates Positive momentum. The RSI at 44.97 is Neutral, neither overbought nor oversold. The STOCH value of 70.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:0767.
Zhong Ji Longevity Science Group Limited Peers Comparison
UnderperformOutperform
Sector (68)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
71 Outperform | HK$380.00M | 6.89 | 5.18% | 5.43% | -1.47% | 2.86% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | HK$377.60M | 5.31 | 2.79% | 4.88% | -12.94% | -15.93% | |
59 Neutral | HK$257.02M | 19.00 | 1.09% | ― | 8.77% | -76.88% | |
53 Neutral | HK$161.86M | -2.46 | 4.61% | ― | -25.74% | ― | |
50 Neutral | HK$299.23M | -17.71 | -11.93% | ― | 121.54% | -8360.00% |
* Financial Sector Average
HK:0767
Zhong Ji Longevity Science Group Limited
0.47
0.08
20.51%
HK:1563
International Alliance Financial Leasing Co., Ltd.
0.15
-0.05
-24.75%
HK:1669
Global International Credit Group Ltd.
0.95
0.43
82.69%
HK:1915
Yangzhou Guangling District Taihe Rural Micro-finance Company Limited Class H
0.27
0.00
0.00%
HK:0605
China Financial Services Holdings Limited
0.80
-0.40
-33.33%
HK:6866
Zuoli Kechuang Micro-finance Co. Ltd. Class H
0.32
0.04
14.29%
Zhong Ji Longevity Science Group Limited Corporate Events
Zhong Ji Longevity Science Delays Circular on Major Cell Lab Acquisition
Jan 16, 2026
Zhong Ji Longevity Science Group Limited, a Hong Kong-listed longevity and life-sciences company focusing on cellular technologies and related healthcare applications, is pursuing an expansion of its interests through the proposed acquisition of 2...
Zhong Ji Longevity Science Group Delays Circular on Cell Lab Stake Acquisition
Dec 22, 2025
Zhong Ji Longevity Science Group Limited has announced a delay in sending to shareholders a circular relating to its proposed major and connected transaction to acquire 25% of the issued share capital of Asian Integrated Cell Laboratory Limited, w...
Zhong Ji Longevity Science Group Announces Board Reshuffle
Nov 27, 2025
Zhong Ji Longevity Science Group Limited announced significant changes in its board composition, effective November 27, 2025. Mr. Lee See Barry has resigned as an independent non-executive director to focus on personal and business commitments, wh...
Zhong Ji Longevity Science Group Announces Board and Committee Structure
Nov 27, 2025
Zhong Ji Longevity Science Group Limited has announced the composition of its board of directors and the roles within various committees. This announcement outlines the leadership structure, which includes executive, non-executive, and independent...
Zhong Ji Longevity Science Group Faces Board Diversity Challenge Amid Leadership Changes
Nov 7, 2025
Zhong Ji Longevity Science Group Limited announced the resignation of two executive directors, Mr. Yan Yifan and Ms. Cao Xie Qiong, with Mr. Yan Li stepping in as the new CEO. The company faces a compliance issue due to a lack of gender diversity ...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.